ScanSource (SCSC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
9 Jan, 2026Executive summary
Net sales declined 15.5% year-over-year to $747.5M for Q2 FY25, driven by soft demand and fewer large deals, partially offset by growth in the Intelisys & Advisory segment.
Gross profit increased 1.0% to $101.7M, with margin up to 13.6% from 11.4% year-over-year, supported by a higher mix of recurring revenue and hybrid distribution strategy.
Recurring revenue grew 31.2% year-over-year, now accounting for over 32% of consolidated gross profit, driven by recent acquisitions.
GAAP net income fell 47.9% to $17.1M, with operating income down 31.2% to $18.4M, reflecting higher SG&A, restructuring, and acquisition-related costs.
Recent acquisitions (Resourcive and Advantix) expanded recurring revenue and next-gen technology offerings for channel partners.
Financial highlights
Gross profit margin improved to 13.6%, with recurring revenue accounting for 32% of consolidated gross profits.
Adjusted EBITDA margin was 4.7%; Adjusted EBITDA declined 8% year-over-year to $35.3M.
Non-GAAP net income was $20.7M, with non-GAAP diluted EPS flat at $0.85 year-over-year.
Free cash flow for the quarter was negative $8M, but $34.3M was generated year-to-date; six-month operating cash flow was $38.6M.
SG&A expenses rose 10.5% to $73.9M, mainly due to higher bad debt expense and acquisition costs.
Outlook and guidance
FY25 guidance reaffirmed: net sales $3.1B–$3.5B, adjusted EBITDA $140M–$160M, and free cash flow of at least $70M.
Management expects demand to improve in the second half of FY25, with cautious optimism based on channel sentiment.
Effective tax rate for fiscal 2025 (excluding discrete items) expected to be 28.5%–29.5%; capital expenditures projected at $8M–$12M.
Latest events from ScanSource
- Recurring revenues and disciplined capital allocation drive margin growth and efficiency.SCSC
47th Annual Raymond James Institutional Investor Conference5 Mar 2026 - Q2 FY26 sales grew 2.5%, but margin pressure led to reduced full-year guidance.SCSC
Q2 20265 Feb 2026 - Sales fell but margins, cash flow, and acquisitions support growth amid market uncertainty.SCSC
Q4 202423 Jan 2026 - Recurring revenue and margin gains offset sales decline; FY25 outlook reaffirmed.SCSC
Q1 202515 Jan 2026 - Hybrid distribution and recurring revenue drive growth, with a focus on cash flow and strategic M&A.SCSC
Raymond James 2024 TMT & Consumer Conference11 Jan 2026 - Recurring revenue now exceeds 30% of gross profit, fueling margin expansion and strategic growth.SCSC
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202514 Dec 2025 - Transformation to a converged hardware and recurring revenue model drives growth and margin expansion.SCSC
Raymond James TMT and Consumer Conference10 Dec 2025 - Shareholders to vote on directors, executive pay, auditor, and new incentive plan amid strong cash flow.SCSC
Proxy Filing1 Dec 2025 - Strong cash flow, margin growth, and governance focus highlight FY2025, with key votes ahead.SCSC
Proxy Filing1 Dec 2025